CannaEvidence
Is this for me?
Is this for me?

Europe · all countries · model B — Controlled national programme

Medical cannabis in Luxembourg

State programme, hospital pharmacies, free to residents

Luxembourg runs a closed state programme since August 2018: a doctor trained and certified by the Direction de la santé prescribes dried flower, oil extracts, Sativex or Epidyolex for three indication groups, and one of four hospital pharmacies hands it over free of charge — but only to people who live in Luxembourg and are insured here.

The hardest fact about Luxembourg. The programme is for residents insured under the Luxembourg system; a visitor or cross-border patient cannot use it, and since 1 January 2025 THC-dominant flower is no longer reordered — only CBD-dominant and balanced THC/CBD flower remain.

Every answer below was read in the law, the register or the official statistic itself. This country is part of the Europe layer: an English page of verified facts, no directory. Where an answer is marked as not published, no official source states it — we did not fill the gap with a guess.

The questions, answered for Luxembourg

How access works here

The one-line answer: can a new patient start today, and through what.

Model B — a controlled national programme: cannabis is a distinct medical category, prescribed by certified doctors and dispensed free through hospital pharmacies to residents.

The Loi du 20 juillet 2018 amended the 1973 drugs law to allow medical use of cannabis « dans des cas exceptionnels et limités » for defined patient groups; it entered into force on 5 August 2018. The Ministry's own description frames it as a public-health mission for patients whose usual treatments no longer suffice.

Source: Loi du 20 juillet 2018 modifiant la loi modifiée du 19 février 1973 (cannabis à usage médical) — page « Usage médical », Portail Santé (santesecu.public.lu) · read 27 September 2026

What may be prescribed

What the law allows a doctor to write on a prescription here.

Dried flowering tops and oily extracts with defined THC/CBD content, plus the authorised medicines Sativex and Epidyolex. Since 1 January 2025 only CBD-dominant and balanced THC/CBD flower is supplied; THC-dominant flower ran out with existing stock.

The Ministry brochure lists « sommités fleuries séchées (THC/CBD définis) », « extraits huileux (THC/CBD définis) » and the medicines Sativex and Epidyolex. The FAQ (updated 1 December 2025) states that from 1 January 2025 THC-dominant flower is no longer reordered and that switching a patient from flower to oil extract requires case-by-case titration rather than a fixed equivalence.

Source: FAQ Cannabis à usage médical — Portail Santé (dernière modification 01.12.2025) · read 27 September 2026

Who may prescribe

Whether you need a specialist, and whether anyone has to approve it first.

Any doctor resident in Luxembourg who has completed the specific training certified by the Direction de la santé. Patients must reside in Luxembourg and be covered by Luxembourg health insurance; the brochure also lists Luxembourg nationality among its criteria.

Brochure: the prescriber must « résider au Luxembourg » and have « suivi au préalable une formation spécifique certifiée par la Direction de la santé »; a doctor without the training can obtain a certified colleague's contact from the Direction de la santé. Patient criteria as printed: « Résider au Luxembourg, Bénéficier de l'assurance maladie luxembourgeoise, Être de nationalité luxembourgeoise ». Indications: advanced or terminal chronic disease with pain; chemotherapy-induced nausea and vomiting; multiple sclerosis with symptomatic spasticity.

Source: « Comment accéder au cannabis médicinal ? » — brochure du ministère de la Santé (2022), Portail Santé · read 27 September 2026

Type of prescription

The form itself: which prescription, how long it is valid, how much it covers.

A secure prescription (ordonnance sécurisée) that must be presented to one of the four dispensing hospital pharmacies within 60 days of issue.

Brochure: « L'ordonnance sécurisée doit être présentée à une pharmacie hospitalière au maximum 60 jours après la date de prescription. » Quantity and duration limits are not stated in the public brochure or FAQ.

Source: « Comment accéder au cannabis médicinal ? » — brochure du ministère de la Santé (2022), Portail Santé · read 27 September 2026

Telemedicine

Whether a prescription can lawfully begin in a video call.

Not published

Not addressed in any official page we opened; the programme is built around certified prescribers and hospital-pharmacy pick-up, not remote prescribing.

Neither the Ministry page, the brochure nor the FAQ mentions video consultations. Treat as not published.

Source: FAQ Cannabis à usage médical — Portail Santé (dernière modification 01.12.2025) · read 27 September 2026

Dispensing

Which pharmacy can actually hand it over.

Four hospital pharmacies dispense the programme's cannabis, some by appointment or after prior notice; community pharmacies do not.

Brochure: « Quatre pharmacies hospitalières dispensent le cannabis selon des modalités spécifiques (rendez-vous requis ou notification préalable selon l'établissement). » The product « est délivré gratuitement au patient ».

Source: « Comment accéder au cannabis médicinal ? » — brochure du ministère de la Santé (2022), Portail Santé · read 27 September 2026

Reimbursement

Whether anyone other than you pays for it.

The state supplies the product free of charge to programme patients — there is no co-payment at the hospital pharmacy.

Brochure: « Le produit est délivré gratuitement au patient. » Sativex and Epidyolex as authorised medicines follow the CNS rules for those specialties; details not on the pages opened.

Source: « Comment accéder au cannabis médicinal ? » — brochure du ministère de la Santé (2022), Portail Santé · read 27 September 2026

Driving

The question with the worst consequences and the least reliable information online.

Driving under the influence of drugs is prohibited; a THC concentration of 1 ng/ml or more in blood is itself a road-traffic offence, and the police page states no exception for prescribed cannabis.

Police Grand-Ducale, 'Stupéfiants': 'la conduite sous l'influence de drogues est interdite'; a THC blood level of ≥ 1 ng/ml constitutes an infraction of the Code de la route. The page gives no article number and no medical-use defence; the Code de la route text on Legilux could not be opened. Separately, the page describes the 2023 rules on adult home consumption and cultivation of up to four plants, which are not a medical route.

Source: Police Grand-Ducale — Législation: Stupéfiants · read 27 September 2026

Travel

Taking it across a border, which is where most published advice is simply wrong.

Not published

Luxembourg is in Schengen: residents can travel within Schengen with a certificate under Article 75 of the Schengen Convention for up to 30 days; the issuing procedure is not described on the pages opened.

The Portail Santé has a page « Voyager avec des médicaments contenant des substances stupéfiantes » (indexed by search engines) that could not be opened in this session; treat details as not verified.

Source: Loi du 20 juillet 2018 modifiant la loi modifiée du 19 février 1973 (cannabis à usage médical) — page « Usage médical », Portail Santé (santesecu.public.lu) · read 27 September 2026

As a visitor or new resident

Four things nobody publishes together: getting a prescription as a non-resident, using a prescription from another EU country, bringing your own medicine in, and whether a foreign video consultation counts.

Visitors and cross-border patients cannot use the programme: it is limited to people who reside in Luxembourg and are insured under the Luxembourg system, prescribed by a certified doctor resident in Luxembourg. Bringing your own medicine in for a short stay follows the Schengen Article 75 certificate rules.

1. Non-resident prescription: excluded by the programme's own criteria (brochure: résider au Luxembourg, assurance maladie luxembourgeoise). 2. Foreign EU prescription: no official statement opened; as elsewhere in the EU, narcotic prescriptions are outside the cross-border recognition rule of Directive 2011/24/EU Art. 11(6) — not verified for Luxembourg. 3. Own medicine: Schengen Art. 75 certificate, 30 days, from your home country's authority. 4. Foreign telemedicine prescriptions: not fillable under the programme.

Source: « Comment accéder au cannabis médicinal ? » — brochure du ministère de la Santé (2022), Portail Santé · read 27 September 2026

What is changing

What is pending in parliament or at the regulator, with dates — or the statement that nothing is.

Since 1 January 2025 the programme supplies only CBD-dominant and balanced THC/CBD flower; THC-dominant flower was phased out with existing stock. No further change is announced on the Ministry pages (FAQ last modified 1 December 2025).

FAQ: from 1 January 2025 « seules les sommités fleuries à dominante CBD et THC/CBD » remain available; THC-dominant supplies not reordered, remaining « jusqu'à épuisement des stocks ». The Ministry page itself was last modified 9 January 2026.

Source: FAQ Cannabis à usage médical — Portail Santé (dernière modification 01.12.2025) · read 27 September 2026

What we can publish for Luxembourg, and what we cannot

Four directories, four honest answers. Where an official register exists we republish it and link every entry back to the source. Where none exists, that is what the page says — a list built out of self-declarations would be worse than no list, and saying so is more useful to you than pretending.

Doctors

No list — by design

Prescribers are doctors certified by the Direction de la santé; the list is not public — the Ministry refers patients to their own doctor or to infocannabis@ms.etat.lu for a certified colleague.

Pharmacies

No list — by design

Four hospital pharmacies dispense; the Ministry brochure names the arrangement but a directory of four state-designated pharmacies adds nothing a reader cannot get from the Ministry.

Products and preparations

No list — by design

The state supplies a small fixed range (CBD-dominant and balanced flower, oil extracts, Sativex, Epidyolex) through four hospital pharmacies; there is no public product register to republish.

Telemedicine platforms

No list — by design

No telemedicine layer exists in a residents-only, hospital-pharmacy programme.

Where this country's law lives

Everything above comes from these texts rather than from another portal's summary. They are listed so you can check us.

Crossing a border with this

Two European rules decide most of what a traveller asks. Directive 2011/24/EU obliges pharmacies to honour prescriptions from another Member State — but only for medicines authorised in the dispensing country, and its Article 11(6) says the rule “shall not apply to medicinal products subject to special medical prescription”, which is where narcotic prescriptions sit. A magistral cannabis preparation is neither authorised nor outside that exclusion, so a cannabis prescription from another country is, as a rule, not dispensable anywhere in Europe. For carrying your own medicine, Article 75 of the Schengen Convention lets a resident of a Schengen state travel with a certified supply for up to 30 days; outside Schengen, national import rules apply. The country-specific answer is above under “As a visitor or new resident”.

Directive 2011/24/EU, Article 11(1) and 11(6) — read on EUR-Lex on 27 September 2026: CELEX 32011L0024.

Other countries with the same model (controlled national programme)

The answers change at every border, and a prescription does not travel with you. Compare before you assume.